Mario Morken Email & Phone Number

Boston, Ma, Us

Cambridge, Massachusetts, Us

Emeryville, Ca, Us

Minneapolis, Minnesota, Us

Head of Business Development at Exosome Diagnostics

Waltham, Ma, Us

Waltham, Ma, Us

Hercules, Ca, Us

Waltham, Ma, Us

Ion Torrent™ Product lines responsible for:The Ion Personal Genome Machine™ (PGM™)Ion OneTouch 2 System™Ion Certified Service Provider Program

Bethesda, Md, Us

Laboratory of Francis S. Collins, Director, National Institutes of HealthFunctional Studies*Carried out experiments on genes implicated in diabetes risk*Participated in brainstorming meetings with Principal Investigator, supervisors, and post docs*Trained lab personnel in techniques, procedures, and use of equipment/roboticsCloning*Familiar with all steps *Worked with a variety of plasmid vectors*Familiar/Proficient in:imaging and use of fluorescent tags such GFP, Bacterial transformation, sequencing of colonies, transfection, and various DNA extraction and purifying techniques*Genome browsers and molecular biology software*Involved in the development of a Novel MALDI-TOF Mass Spec method to detect:Allele Specific expression & representation*Served as authoritative consultant to researchers on technical aspects of automated genotypingPublications, Awards, and Presentation*Distinguished Performance Award for 2008, 2009*Attended and presented in bi-weekly lab meetings, NHGRI intramural retreat, and conferences involving other Principal Investigators from Michigan, USC, and Finland*Pathways Tuition Award*Up to date with current literature*Attended NIH campus talks, events, conferences, and courses*Rotated part time in NHGRI Technology Transfer office in 2012*Represented NHGRI at the 2012 International BIO convention in BostonSelected Publications:Heritable Individual Specific and Allele-Specific Chromatin Signatures in Humans. Science. Apr 9 2010-McDaniell R, {6 others}, Morken MA, Kucera KS, Battenhouse A, Keefe D, Collins FS, Willard HF, Lieb JD, Furey TS, Crawford GE, Iyer VR, Birney E. Effects of 34 Risk Loci for Type 2 Diabetes or Hyperglycemia on Lipoprotein Subclasses and Their Composition in 6,580 Non-diabetic Finnish Men. Diabetes, May 2011-Alena Stančáková, {4 others}, Mario A. Morken, Francis S. Collins, Anne U. Jackson, Michael L. Boehnke, Johanna Kuusisto, Mika Ala-Korpela, Markku Laakso27 current co-author publications

Gaithersburg, Md, Us

Responsibilities-Processed samples using different technologies for profit generating production process-Hybridization of samples using Affymetrix Gene Expression Arrays and 500K SNP arrays-Helped with Process Improvement, Training, and Alternative Platform Evaluation -Contributed to developing accurate and efficient QC methods-Implemented measures to better track samples, and track individual lot numbers of reagents being used-Trained new employees and temporary workers in all processes-Familiar with genotyping software-Created SOPs and directly worked with QA department for approval Platforms and Technologies-cDNA, IVT, SNP, and Microarray production laboratory-Responsible for large studies hybridizing thousands of samples on Affymetrix SNP & expression arrays-Isolated and extracted DNA from the sample tissue-Processed samples from isolation through hybridization on microarrays-Familiar with multiple DNA extraction techniques with and without robotics-Agilent aCGH and ABI SNPlex-Involved in converting proof of concept to a service offering for both technologiesMolecular Techniques -Normalization of DNA, DNA quantitation, restriction enzyme digestion, DNA ligation, PCR, DNA purification, Fragmentation, End-labeling, hybridization, staining and scanning microarrays, etc.-cDNA and IVT reactions and magnetic bead cleanup of these reactions -Detection of DNA copy number variations across the genome using Agilent aCGH-Analysis of DNA and detection of SNPs through capillary electrophoresis using the ABI 3730 DNA analyzer

M.S., M.B.A., Biotechnology, Business

B.S. Biology

Education record